Jacobus Pharmaceutical
6 clinical trials · Sponsor
◉ Watch Jacobus Pharmaceutical
| Record | Firm | Date |
|---|---|---|
| Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome (NCT01511978) | Jacobus Pharmaceutical | 2012-01-01 |
| High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children (NCT00495521) | Jacobus Pharmaceutical | 2007-06-01 |
| High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease (NCT00417690) | Jacobus Pharmaceutical | 2007-01-01 |
| Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris (NCT00429533) | Jacobus Pharmaceutical | 1996-11-01 |
| Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC) (NCT00002043) | Jacobus Pharmaceutical | |
| A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00002283) | Jacobus Pharmaceutical |
Track Jacobus Pharmaceutical automatically
Every clearance here is in the API, with alerts when new ones post.